Konstantinos Voumvourakis Selected Research

Ad26COVS1

2/2022

Guillain-Barré syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konstantinos Voumvourakis Research Topics

Disease

13	Ischemic Stroke 01/2021 - 11/2011
11	Stroke (Strokes) 12/2021 - 11/2011
7	Multiple Sclerosis 02/2022 - 09/2014
3	Atherosclerosis 12/2021 - 03/2016
3	Atrial Fibrillation 05/2017 - 05/2014
3	Transient Ischemic Attack 01/2017 - 05/2014
3	Relapsing-Remitting Multiple Sclerosis 01/2016 - 01/2015
2	Neurologic Manifestations (Neurological Manifestations) 02/2022 - 01/2022
2	Nervous System Diseases (Neurological Disorders) 02/2022 - 01/2017
2	Hemorrhagic Stroke 01/2021 - 09/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2017 - 09/2016
2	Hemorrhage 09/2016 - 05/2014
2	Atrophy 09/2015 - 01/2015
2	Disease Progression 01/2015 - 07/2005
2	Fatigue 09/2014 - 07/2014
2	Hypertension (High Blood Pressure) 05/2014 - 05/2013
1	Encephalomyelitis (Myeloencephalitis) 02/2022
1	Guillain-Barre Syndrome 02/2022
1	Inflammation (Inflammations) 12/2021
1	Atherosclerotic Plaque (Atheroma) 12/2021
1	Foreign-Body Reaction 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Pulmonary Arterial Hypertension 01/2020
1	Hyperglycemia 09/2019
1	Hypoglycemia (Reactive Hypoglycemia) 09/2019
1	Vasculitis (Vasculitides) 11/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2017
1	Cerebral Hemorrhage 01/2017
1	Patent Foramen Ovale 09/2016
1	Venous Insufficiency 01/2016
1	Hyperemia 01/2016
1	Cognitive Dysfunction 08/2015
1	Hypothyroidism 08/2015
1	Necrosis 07/2015
1	Hydrocephalus (Hydrocephaly) 01/2015
1	Thrombosis (Thrombus) 01/2015
1	Myasthenia Gravis 06/2014
1	Diabetes Mellitus 05/2014
1	Myocardial Infarction 05/2014
1	Heart Failure 05/2014
1	Dyspepsia (Indigestion) 05/2014
1	Embolism (Embolus) 05/2014
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2014
1	Neuromyelitis Optica (Devic's Disease) 01/2014
1	Exanthema (Rash) 01/2014
1	Arthralgia (Joint Pain) 01/2014
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 09/2013
1	Alcoholism (Alcohol Abuse) 09/2013

Drug/Important Bio-Agent (IBA)

3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2022 - 03/2016
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 04/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2014
3	InterferonsIBA 01/2020 - 10/2017
2	AutoantibodiesIBA 02/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 06/2014
2	Dabigatran FDA Link 09/2016 - 05/2014
2	mesoglycanIBA 09/2015 - 11/2014
2	EnzymesIBA 08/2015 - 09/2010
2	Adenosine Triphosphatases (ATPase)IBA 08/2015 - 09/2013
2	Biological ProductsIBA 09/2014 - 07/2014
1	Angiotensin-Converting Enzyme 2IBA 02/2022
1	Ad26COVS1IBA 02/2022
1	Neuropilin-1IBA 02/2022
1	Cell Surface ReceptorsIBA 02/2022
1	Coenzyme A (CoA)IBA 02/2022
1	Oxidoreductases (Dehydrogenase)IBA 02/2022
1	AdipokinesIBA 12/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	SynucleinsIBA 01/2021
1	Tenecteplase FDA Link 01/2021
1	Dimethyl FumarateIBA 10/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2016
1	RivaroxabanIBA 09/2016
1	AnticoagulantsIBA 09/2016
1	N-benzoyl-N-phenylhydroxylamineIBA 01/2016
1	nitazoxanide (NTZ)FDA Link 01/2016
1	IronIBA 01/2016
1	Natalizumab (Tysabri)FDA Link 01/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	Thyroid HormonesIBA 08/2015
1	Propylthiouracil FDA Link 08/2015
1	U 74389FIBA 07/2015
1	InterleukinsIBA 07/2015
1	Cholinergic ReceptorsIBA 06/2014
1	AntibodiesIBA 06/2014
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 06/2014
1	Immunoglobulin G (IgG)IBA 01/2014
1	Antinuclear AntibodiesIBA 01/2014
1	Thiamine (Aneurin)FDA Link 09/2013
1	AntioxidantsIBA 09/2013

Therapy/Procedure

12	Therapeutics 01/2021 - 05/2014
2	Thrombectomy 01/2021 - 09/2019
2	Secondary Prevention 11/2020 - 09/2016
1	Stents 01/2015
1	Duration of Therapy 01/2015
1	Length of Stay 05/2014